Overview
Glutaric aciduria type 1 (GA1) is an inherited metabolic disorder characterized by deficiency of the enzyme electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO), leading to accumulation of glutaric and related organic acids. This accumulation can cause neurological damage, particularly in early childhood, but can also present with diverse symptoms in adulthood 1.Diagnosis
Key Diagnostic Criteria: Elevated urinary glutaric acid (>4 mmol/mol creatinine) and 3-hydroxyglutaric acid (>1 mmol/mol creatinine) 1.
Recommended Tests: Urinary organic acid analysis, plasma glutaryl carnitine levels 1.
Imaging Findings: MRI may show confluent bilateral symmetric white matter signal abnormalities, Sylvian fissure widening, and cerebral atrophy 1.Management
First-Line Treatment: L-carnitine supplementation to mitigate metabolic derangements 1.
Adjunctive Treatments: Caloric support with dextrose infusion during critical periods, such as peripartum management 2.
Dietary Management: High-caloric, protein-rich diet with essential amino acid supplementation, particularly in cases of malnutrition 3.Special Populations
Pregnancy: Ensure adequate caloric intake and carnitine supplementation during delivery to prevent encephalopathic crisis 2.
Malnutrition: Address nutritional deficiencies, especially essential amino acids and trace elements like zinc, to manage complications like acrodermatitis enteropathica-like skin lesions 3.Key Recommendations
Perform urinary organic acid testing in patients with suspected leukodystrophies to identify treatable metabolic disorders like GA1 (Evidence: Moderate 1).
Maintain adequate caloric intake and carnitine supplementation during critical periods, such as pregnancy and delivery, to prevent metabolic crises in GA1 patients (Evidence: Expert opinion 2).
Supplement with a high-calorie, protein-rich diet and essential nutrients (e.g., zinc) in GA1 patients experiencing malnutrition to address associated complications (Evidence: Weak 3).References
1 Badve MS, Bhuta S, Mcgill J. Rare presentation of a treatable disorder: glutaric aciduria type 1. The New Zealand medical journal 2015. link
2 Ituk US, Allen TK, Habib AS. The peripartum management of a patient with glutaric aciduria type 1. Journal of clinical anesthesia 2013. link
3 Niiyama S, Koelker S, Degen I, Hoffmann GF, Happle R, Hoffmann R. Acrodermatitis acidemica secondary to malnutrition in glutaric aciduria type I. European journal of dermatology : EJD 2001. link
4 Shigeoka S, Nakano Y. Characterization and molecular properties of 2-oxoglutarate decarboxylase from Euglena gracilis. Archives of biochemistry and biophysics 1991. link90160-k)